scholarly article | Q13442814 |
P819 | ADS bibcode | 1993PNAS...9010280S |
P356 | DOI | 10.1073/PNAS.90.21.10280 |
P932 | PMC publication ID | 47758 |
P698 | PubMed publication ID | 8234289 |
P5875 | ResearchGate publication ID | 14965579 |
P2093 | author name string | Hayashi Y | |
Ohki M | |||
Shimizu K | |||
Kaneko Y | |||
Asano S | |||
Ichikawa H | |||
Ohira M | |||
Tojo A | |||
Maseki N | |||
P2860 | cites work | Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours | Q24298221 |
The erg gene: a human gene related to the ets oncogene | Q24299030 | ||
The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active | Q24609161 | ||
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation | Q28295357 | ||
Structure and expression of human Fli-1 gene | Q34253097 | ||
A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. | Q34255162 | ||
The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors | Q34262934 | ||
Isolation and regional mapping of DNA sequences unique to human chromosome 21. | Q35199586 | ||
Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids | Q35200986 | ||
Assignment of anonymous DNA probes to specific intervals of human chromosomes 16 and X. | Q35564622 | ||
Chromosome aberrations and cancer | Q37538405 | ||
t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1 | Q37627380 | ||
Molecular and functional characterization of the promoter of ETS2, the human c-ets-2 gene | Q37685279 | ||
Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. | Q41685189 | ||
Molecular assignment of a translocation breakpoint in acute myeloid leukemia with t(8;21). | Q41685840 | ||
The ets gene family. | Q42111288 | ||
Adenine phosphoribosyltransferase deficiency in cultured mouse mammary tumor FM3A cells resistant to 4-carbamoylimidazolium 5-olate | Q42801151 | ||
A primary map of 24 loci on human chromosome 16. | Q43438436 | ||
Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation | Q43833895 | ||
Sequence-tagged sites (STSs) for a set of mapped markers on chromosome 21 | Q67577183 | ||
Translocation (8;21) and its variants in acute nonlymphocytic leukemia. The relative importance of chromosomes 8 and 21 to the genesis of the disease | Q67921951 | ||
Translocation t(16;21) in acute nonlymphocytic leukemia with abnormal eosinophils | Q67989095 | ||
t(16;21) in a Ph positive CML | Q68157720 | ||
The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence | Q68624466 | ||
t(16;21)(p11.2;q22): a recurrent primary rearrangement in ANLL | Q70162122 | ||
A NotI restriction map of the entire long arm of human chromosome 21 | Q70485045 | ||
The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1 | Q70609736 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
myeloid leukemia | Q11688946 | ||
P1104 | number of pages | 5 | |
P304 | page(s) | 10280-10284 | |
P577 | publication date | 1993-11-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation | |
P478 | volume | 90 |
Q42684235 | A DNA Contact Map for the Mouse Runx1 Gene Identifies Novel Haematopoietic Enhancers |
Q38504257 | A Recurrent Translocation, t(16;21)(q24;q22), Associated with Acute Myelogenous Leukemia: Identification by Fluorescence In Situ Hybridization |
Q33885920 | A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein |
Q77344066 | A novel EWS-ERG rearrangement generating two hybrid mRNAs in a peripheral primitive neuroectodermal tumour (pPNET) with a t(15;22) translocation |
Q34640225 | A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites |
Q36691805 | Adult human sarcomas. I. Basic science |
Q43922213 | An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. |
Q38050656 | B-lineage transcription factors and cooperating gene lesions required for leukemia development |
Q41838202 | BAALC and ERG Expression in Egyptian Patients with Acute Myeloid Leukemia, Relation to Survival and Response to Treatment |
Q39454928 | BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway |
Q36532514 | Cellular and molecular mechanisms of synovial joint and articular cartilage formation |
Q28140198 | Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human |
Q52512616 | Chromosomal translocations in human cancer. |
Q57051122 | Comparative structure analysis of the ETSi domain of ERG3 and its complex with the E74 promoter DNA sequence |
Q36564203 | Constitutive c-ets2 expression in M1D+ myeloblast leukemic cells induces their differentiation to macrophages |
Q37341273 | Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia |
Q33385721 | Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage |
Q33960227 | Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS). |
Q21710685 | ELF4 is fused to ERG in a case of acute myeloid leukemia with a t(X;21)(q25–26;q22) |
Q34091302 | ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells |
Q38681610 | ERG expression in prostate cancer: biological relevance and clinical implication |
Q36652758 | ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development |
Q24634316 | EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations |
Q34298092 | EWS‐FLI‐1 and EWS‐ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor |
Q30493247 | Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity |
Q44991765 | Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription |
Q41337243 | Establishment and characterization of IRTA17 and IRTA21, two novel acute non-lymphocytic leukaemia cell lines with t(16;21) translocation |
Q40726018 | Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells |
Q77769562 | Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice |
Q35592105 | Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis |
Q71678482 | Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22) |
Q40968149 | Gene rearrangements in Ewing's sarcoma |
Q42278719 | Genetic mutations in RNA-binding proteins and their roles in ALS. |
Q33880683 | Genomic organization of the human e1af gene,a member of Ets transcription factors. |
Q22010700 | Human chromosomal localization, tissue/tumor expression, and regulatory function of the ets family gene EHF |
Q37281690 | Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines. |
Q45730515 | Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites |
Q73367499 | Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma |
Q33988757 | Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines |
Q34051653 | Molecular genetics of chromosome translocations involving EWS and related family members |
Q34135434 | Molecular pathways: targeting ETS gene fusions in cancer |
Q74450239 | Molecular phylogeny of the ETS gene family |
Q44830496 | Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells |
Q44645793 | Mutual repression of transcriptional activation between the ETS-related factor ERG and estrogen receptor |
Q34772060 | Myxochondroid metaplasia of the plantar foot: a distinctive pseudoneoplastic lesion resembling nuchal fibrocartilaginous pseudotumor and the equine digital cushion |
Q38354873 | Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia |
Q92410968 | Oncogenic ETS Factors in Prostate Cancer |
Q38508281 | Partial chromosome 21 amplification in a child with acute lymphoblastic leukemia. |
Q47863498 | Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations. |
Q37083967 | Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder |
Q35022522 | Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins |
Q38320097 | Purification, crystallization and preliminary X-ray crystallographic analysis of the ETS domain of human Ergp55 in complex with the cfos promoter DNA sequence. |
Q34750188 | Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders? |
Q38823486 | Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells |
Q26747155 | Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERG |
Q24669651 | Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells |
Q34316135 | Role of Ets transcription factors in mammary gland development and oncogenesis |
Q27730257 | Solution structure of the ets domain of Fli-1 when bound to DNA |
Q34326572 | Structural modeling and DNA binding autoinhibition analysis of Ergp55, a critical transcription factor in prostate cancer. |
Q24533281 | TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis |
Q46786388 | TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease |
Q89157968 | Targeting Transcription Factors for Cancer Treatment |
Q34555986 | The ETS family of oncogenic transcription factors in solid tumours. |
Q52170371 | The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis. |
Q24811898 | The Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells |
Q26799478 | The biology of pediatric acute megakaryoblastic leukemia |
Q52168068 | The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. |
Q38444138 | The oncogene ERG: a key factor in prostate cancer |
Q28281239 | The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells |
Q36183609 | Transcription factor ERG and joint and articular cartilage formation during mouse limb and spine skeletogenesis. |
Q41589633 | Transcriptional regulation during myelopoiesis |
Q42521353 | Utility of immunohistochemical detection of prostate-specific Ets for the diagnosis of benign and malignant prostatic epithelial lesions |
Q35088118 | Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements |
Q36545848 | YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model |
Search more.